NCT03682913

Brief Summary

Obsessive-compulsive disorder (OCD) is a severe mental illness characterized by repetitive behaviors that a person feels compelled to perform. It has been demonstrated that stimuli in the environment can trigger the compulsive urge, perpetuating the OCD cycle. The main goal of the current proposal, which is based on exciting pilot data, is to test a novel computerized training program to create an association between OCD-related stimuli, which typically trigger the compulsive urge, and the brain system responsible for stopping. The idea is that once this system is triggered, it will be easier for patients to stop the compulsive urge.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2018

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2018

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

August 23, 2018

Completed
1 month until next milestone

First Posted

Study publicly available on registry

September 25, 2018

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2019

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2019

Completed
Last Updated

September 27, 2018

Status Verified

September 1, 2018

Enrollment Period

1.1 years

First QC Date

August 23, 2018

Last Update Submit

September 25, 2018

Conditions

Outcome Measures

Primary Outcomes (2)

  • fMRI- changed inhibition levels in the pre-SMA area in experimental group in comparison to control group

    During tasks that require inhibition

    One week after P-CIT training starts

  • fMRI- changed inhibition levels in the rIFG area in experimental group in comparison to control group

    During tasks that require inhibition

    One week after P-CIT training starts

Secondary Outcomes (3)

  • Behavioural- Y-bocs (Yale-Brown Obsessive-Compulsive Scale) score- change in OCD symptoms in experimental group in comparison to placebo group

    One week after P-CIT (Personalized Inhibitory Control Training for Compulsive Behavior Change) training

  • Behavioural- M.I.N.I (Mini-International Neuropsychiatric Interview) score- change in OCD symptoms in experimental group in comparison to placebo group

    One week after P-CIT (Personalized Inhibitory Control Training for Compulsive Behavior Change) training

  • Behavioural- OCI-R (Obsessive-Compulsive Inventory) score- change in OCD symptoms in experimental group in comparison to placebo group

    One week after P-CIT (Personalized Inhibitory Control Training for Compulsive Behavior Change) training

Study Arms (2)

P-CIT protocol

EXPERIMENTAL

OCD patients who receive the P-CIT intervention.

Behavioral: P-CIT protocol

Placebo

PLACEBO COMPARATOR

OCD patients who don't receive the P-CIT intervention.

Behavioral: Placebo

Interventions

P-CIT protocolBEHAVIORAL

Personalized inhibitory control training for one week.

P-CIT protocol
PlaceboBEHAVIORAL

without personalized inhibitory control training for one week.

Placebo

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • OCD patients

You may not qualify if:

  • Metal/ electronic device
  • Under the age of 18
  • Pregnant women
  • Tattoos that cover over 10% of body mass
  • Chronically ill patients
  • Psychosis/ Bi-polar
  • Substance abuse
  • Sever depression
  • Active suicide thoughts
  • Hearing loss

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Hebrew University of Jerusalem

Jerusalem, Israel

RECRUITING

Central Study Contacts

Shahaf Leshem, B.A.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

August 23, 2018

First Posted

September 25, 2018

Study Start

July 1, 2018

Primary Completion

July 30, 2019

Study Completion

August 30, 2019

Last Updated

September 27, 2018

Record last verified: 2018-09

Locations